Skip to main content
. 2018 Aug 29;374(3):607–617. doi: 10.1007/s00441-018-2905-z

Fig. 3.

Fig. 3

The S117A-FGF2 protection from Dox requires ERK activity. (a) The effect of S117A-FGF2 on pERK/ERK ratio after 30 min cardiomyocyte stimulation and after Dox exposure for another 30 min. Images of the corresponding western blots probed for anti-pERK or anti-ERK are also included (a′, n = 3). (b) The effect of UO126 (inhibitor of ERK activation) on S117A-FGF2 protection from Dox-induced LDH release. Brackets point to groups that are significantly different from each other. In the presence of UO126, S117A-FGF2 is unable to reduce Dox-induced LDH release